The American Society of Transplantation (AST) held an APOL1 Consensus Building Meeting December 17-18, 2015 to bring experts in the field together to address the potential impact of the APOL1 gene variants on organ donation and transplantation.
Sponsored by Novartis, the AST's APOL1 Consensus Building Meeting meeting included nationally recognized experts in kidney disease, transplantation, and public policy. A number of governmental stakeholders participated in the meeting, including key leaders from HRSA, NIAID, NIDDK, NIMHD, AOPO, and UNOS.
Advertisements
This content was developed independently by AST and supported by a financial contribution from
